Literature DB >> 8770699

Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B.

J P Witty1, S A Foster, G P Stricklin, L M Matrisian, P H Stern.   

Abstract

The role of matrix metalloproteinases in parathyroid hormone (PTH)-induced bone resorption was assayed using a fetal rat limb bone culture system. Cotreatment of bones with PTH and recombinant inhibitor of metalloproteinases, TIMP-1, in vitro, inhibited the PTH-stimulated 45Ca release from the limb bones without affecting beta-glucuronidase release. TIMP-1 was fully effective when added during only the final 24 h of a 72 h culture with PTH but was ineffective when added for only the first 24 h of the 72 h culture. In contrast, calcitonin (CT) was effective when added for either the first 24 or the final 24 h of the culture. Using in situ hybridization, the mRNA for collagenase was detected in mononuclear cells of cultured bone. Treatment of the bones with PTH resulted in an increase in the number of cells producing collagenase mRNA, some of which had osteoclastic morphology, PTH also caused a dramatic induction of the mRNA for the 92-kD gelatinase B metalloproteinase in both mononuclear and osteoclastic cells. There was no detectable mRNA for the metalloproteinases stromelysin-1, stromelysin-2, or matrilysin in PTH-treated or control cultures. These results suggest that PTH-induced bone resorption is mediated, at least in part, by the induction of collagenase and gelatinase B mRNA in bone cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770699     DOI: 10.1002/jbmr.5650110111

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.

Authors:  S Bord; A Horner; R M Hembry; J J Reynolds; J E Compston
Journal:  J Anat       Date:  1997-07       Impact factor: 2.610

2.  Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation.

Authors:  Nagarajan Selvamurugan; Emi Shimizu; Minnkyong Lee; Tong Liu; Hong Li; Nicola C Partridge
Journal:  FEBS Lett       Date:  2009-03-03       Impact factor: 4.124

Review 3.  An odyssey from breast to bone: multi-step control of mammary metastases and osteolysis by matrix metalloproteinases.

Authors:  A Lochter; M J Bissell
Journal:  APMIS       Date:  1999-01       Impact factor: 3.205

4.  Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Authors:  T Yoneda; A Sasaki; C Dunstan; P J Williams; F Bauss; Y A De Clerck; G R Mundy
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells.

Authors:  Andreas M Stark; Bartosz Anuszkiewicz; Rolf Mentlein; Toshiyuki Yoneda; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

Review 6.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

7.  On the origin of the catalytic power of carboxypeptidase A and other metalloenzymes.

Authors:  Alexandra Vardi Kilshtain; Arieh Warshel
Journal:  Proteins       Date:  2009-11-15

Review 8.  Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis.

Authors:  Tian-Liang Ma; Peng Zhu; Zhuo-Ran Ke; Jing-Xian Chen; Yi-He Hu; Jie Xie
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

9.  Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.

Authors:  Zhe Qian; Xiaoting Zhao; Mei Jiang; Wenyun Jia; Chunyan Zhang; Yue Wang; Baolan Li; Wentao Yue
Journal:  BMC Cancer       Date:  2012-10-02       Impact factor: 4.430

Review 10.  Genetic Susceptibility and Protein Expression of Extracellular Matrix Turnover-Related Genes in Oral Submucous Fibrosis.

Authors:  Ru-Hsiu Cheng; Yi-Ping Wang; Julia Yu-Fong Chang; Yu-Hwa Pan; Mei-Chi Chang; Jiiang-Huei Jeng
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.